Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Helena Bleken Østergaard"'
Autor:
Helena Bleken, Østergaard, Valerie, Humphreys, Ellen Margo, Hengeveld, Julie Broe, Honoré, François, Mach, Frank L J, Visseren, Jan, Westerink, Gourav, Yadav, Ofri, Mosenzon
Publikováno v:
Diabetes, Obesity and Metabolism. 25:435-443
To assess the potential gain in the number of life-years free of a (recurrent) cardiovascular disease (CVD) event with optimal cardiovascular risk management (CVRM) and initiation of glucose-lowering agents with proven cardiovascular benefit in peopl
Autor:
Jan Westerink, Kasper Sommer Matthiessen, Solomon Nuhoho, Udi Fainberg, Michael Lyng Wolden, Helena Bleken Østergaard, Frank Visseren, Naveed Sattar
Publikováno v:
Diabetes Care
OBJECTIVE Semaglutide, a glucagon-like peptide 1 receptor agonist, reduced major adverse cardiovascular events (MACE) in people with type 2 diabetes (T2D) at high risk of cardiovascular disease (CVD) in a post hoc analysis of pooled data from Trial t
Autor:
null Helena Bleken Østergaard, null Valerie Humphreys, null Ellen Margo Hengeveld, null Julie Broe Honore, null François Mach, null Frank L. J. Visseren, null Jan Westerink, null Gourav Yadav, null Ofri Mosenzon, null the CAPTURE investigators
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c90f3a4db036d198b49e009f2a3cbb85
https://doi.org/10.1111/dom.14887/v2/response1
https://doi.org/10.1111/dom.14887/v2/response1
Autor:
Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, Owen Taylor, Lisa Pennells, Stephen Kaptoge, Carmen Petitjean, Zhe Xu, Fanchao Shi, John William McEvoy, William Herrington, Frank L J Visseren, Angela Wood, Björn Eliasson, Naveed Sattar, Sarah Wild, Emanuele Di Angelantonio, Jannick A N Dorresteijn
Publikováno v:
2022, ' Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes : an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2) ', European Journal of Preventative Cardiology . https://doi.org/10.1093/eurjpc/zwac232
Aims The 2021 European Society of Cardiology cardiovascular disease (CVD) prevention guidelines recommend the use of (lifetime) risk prediction models to aid decisions regarding intensified preventive treatment options in adults with Type 2 diabetes,
Autor:
Helena Bleken, Østergaard, Imre, Demirhan, Jan, Westerink, Marianne C, Verhaar, Folkert W, Asselbergs, Gert J, de Borst, L Jaap, Kappelle, Frank L J, Visseren, Joep, van der Leeuw
Publikováno v:
European Journal of Clinical Investigation. 52
Patients with cardiovascular disease (CVD) are at higher risk of kidney function decline. The current study aimed to examine the association of lifestyle changes with kidney function decline in patients with manifest CVD.A total of 2260 patients from
Autor:
Helena Bleken Østergaard, Stephanie H. Read, Naveed Sattar, Stefan Franzén, Nynke Halbesma, Jannick A.N. Dorresteijn, Jan Westerink, Frank L.J. Visseren, Sarah H. Wild, Björn Eliasson, Joep van der Leeuw
Publikováno v:
Østergaard, H B, Read, S H, Sattar, N, Franzén, S, Halbesma, N, Dorresteijn, J A N, Westerink, J, Visseren, F L J, Wild, S H, Eliasson, B & van der Leeuw, J 2022, ' Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes : 10-Year and Lifetime Risk Prediction Models ', Clinical Journal of the American Society of Nephrology, vol. 17, no. 12, pp. 1783-1791 . https://doi.org/10.2215/CJN.05020422
BACKGROUND AND OBJECTIVES: Individuals with type 2 diabetes are at a higher risk of developing kidney failure. The objective of this study was to develop and validate a decision support tool for estimating 10-year and lifetime risks of kidney failure
Autor:
L. Jaap Kappelle, Gert J. de Borst, Joep van der Leeuw, Helena Bleken Østergaard, Jan Westerink, Michiel L. Bots, Frank L.J. Visseren, Marianne C. Verhaar, Folkert W. Asselbergs
Publikováno v:
Journal of Nephrology
Journal of nephrology, 34(5), 1511-1520. Wichtig Publishing
Journal of nephrology, 34(5), 1511-1520. Wichtig Publishing
Background Patients with cardiovascular disease (CVD) are at increased risk of end-stage kidney disease (ESKD). Insights into the incidence and role of modifiable risk factors for end-stage kidney disease may provide means for prevention in patients
Publikováno v:
Diabetes Care. 44:e139-e139
With great interest we read the recent study by Vistisen et al. (1) wherein a prediction model for end-stage kidney disease (ESKD) in patients with type 1 diabetes was derived and validated. The model is intended to inform clinical decision-making by
Publikováno v:
Ugeskrift for laeger. 177(17)
The symposium IAS Towards an HIV Cure was held in Melbourne, Australia, in July 2014. There are several challenges regarding an HIV cure, among these the reservoir of latently infected CD4+ T cells which are hidden from the immune system. A new promi